跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,363 条关于
“Eisai Co Ltd”
全部
18,363
临床试验
4,287
药物
1,793
机构
4,355
资讯
7,928
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
去年
Newron Pharmaceuticals Expands Evenamide Reach in Asia with New Licensing Agreements
去年
Eisai Launches Chocola BB Nightwell: Novel Sleep-Time Fatigue Recovery Drink
去年
Eisai and Sato Pharmaceutical Restructure Nailin Antifungal Marketing Partnership in Japan
2年前
FDA Requires Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer's Disease
去年
Eisai Launches Beova Tablets for Overactive Bladder Treatment in Thailand
去年
Eisai Partners with SciClone to Expand Tasurgratinib Access in Greater China for Biliary Tract Cancer Treatment
去年
Eisai and Biogen Launch Alzheimer's Drug Leqembi in South Korea
去年
Eisai Launches DAYVIGO, First Orexin Receptor Antagonist for Insomnia Treatment in China
去年
Eisai's Anti-MTBR Tau Antibody E2814 Shows Promise in Early Alzheimer's Disease
第 1 页,共 793 页
上一页
下一页